March 16 (Reuters) - Outlook Therapeutics Inc OTLK.O:
OUTLOOK THERAPEUTICS ANNOUNCES NEW $18.4 MILLION NON-CONVERTIBLE NOTE FINANCING AND AMENDMENT TO EXISTING CONVERTIBLE NOTE
OUTLOOK THERAPEUTICS INC - EXTENDS MATURITY DATE OF EXISTING CONVERTIBLE NOTE TO DECEMBER 31, 2026
OUTLOOK THERAPEUTICS INC - LENDER CONFIRMS EXISTING NOTE IS NOT IN DEFAULT
OUTLOOK THERAPEUTICS INC - ENTERS $18.4 MILLION NEW NOTE, EXPECTS $17 MILLION NET PROCEEDS
OUTLOOK THERAPEUTICS INC - PROCEEDS FROM NEW NOTE TO PAY DOWN EXISTING NOTE, $10.8 MILLION PRINCIPAL AND INTEREST REMAINING ON EXISTING NOTE